Combining the differentiating effect of panobinostat with the apoptotic effect of arsenic trioxide leads to significant survival benefit in a model of t(8;21) acute myeloid leukemia
Jessica M. Salmon(Peter MacCallum Cancer Centre), Ricky W. Johnstone(The University of Melbourne)
Cited by 24
Related Papers
New and emerging HDAC inhibitors for cancer treatment
|Journal of Clinical Investigation|2014|1.4k
BET-Bromodomain Inhibitors Engage the Host Immune System and Regulate Expression of the Immune Checkpoint Ligand PD-L1
|Cell Reports|2017|297
Functional Crosstalk between Type I and II Interferon through the Regulated Expression of STAT1
|PLoS Biology|2010|196